Home
Conditions
Neoplasms, Neuroepithelial

Clinical trial condition

Neoplasms, Neuroepithelial

Explore clinical trials studying Neoplasms, Neuroepithelial. Study availability and eligibility vary by location and protocol.

2,951 public trials 642 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Neuroepithelial trial results

Recruiting

Study of Pembrolizumab and M032 (NSC 733972)

NCT05084430

Conditions: Anaplastic Astrocytoma, Astrocytoma, Disease Attributes, +14 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

View Trial Details

Recruiting

A Study to Evaluate the Safety of a Stem Cell-Based Gene and Cell Therapy in Patients With Newly Diagnosed Glioblastoma

NCT07143812

Conditions: Astrocytoma, Glioblastoma, Glioblastoma (GBM), +9 more
Locations: Bundang CHA Medical Center Seongnam, Kyunggido, South Korea

View Trial Details

Recruiting

131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2)

NCT05450744

Conditions: Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +9 more
Locations: Royal North Shore Hospital Sydney, New South Wales, Australia

Gold Coast University Hospital Gold Coast, Queensland, Australia

Royal Adelaide Hospital Adelaide, South Australia, Australia

Olivia Newton John Cancer Research Institute/Austin Health Melbourne, Victoria, Australia

View Trial Details

Recruiting

5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours

NCT06630260

Conditions: Astrocytoma, Diffuse Hemispheric Glioma, H3 G34-Mutant, Glioblastoma, +11 more
Locations: Cambridge University Hospitals Cambridge, United Kingdom

The Royal Marsden Hospital - Drug Development Unit Sutton, United Kingdom

The Royal Marsden Hospital - Neuro-Oncology Unit Sutton, United Kingdom

View Trial Details

Recruiting

Key Longitudinal Associations With Risk and Glioblastoma Outcomes

NCT06625684

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +19 more
Locations: Duke University Durham, North Carolina, United States

View Trial Details

Recruiting

Study of Prognostic Biomarkers of Survival at 6 Months for Patients Treated With Bevacizumab Glioblastomas in First Relapse After Failure of Radiochemotherapy

NCT03144167

Conditions: Astrocytoma, Chemotherapy, Glioblastoma, +9 more
Locations: CHU Amiens Picardie Amiens, Picardie, France

View Trial Details

Recruiting

Control Cohort CTRL COH

NCT05370079

Conditions: Amyotrophic Lateral Sclerosis, Astrocytoma, Basal Ganglia Diseases, +25 more
Locations: Hospices Civils de Lyon Bron, France

View Trial Details

Recruiting

Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma

NCT05465954

Conditions: Astrocytoma, Glioblastoma, Glioma, +11 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Recruiting

A Multi-Arm, Platform Trial For Relapsed Neuroblastoma

NCT07334301

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +8 more
Locations: Sydney Children's Hospital (SCH) Sydney, Australia

St. Anna Children´s Hospital Vienna, Austria

Cliniques Universitaires Saint-Luc (CUSL) Brussels, Belgium

Starship Children's Hospital (SSH) Auckland, New Zealand

View all 23 locations

View Trial Details

Recruiting

Vorasidenib in CNS WHO Grade 2 IDH-mutant Diffuse Glioma

NCT07240662

Conditions: Glioma, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations: Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg Heidelberg, Germany

View Trial Details

Neoplasms, Neuroepithelial

Neoplasms, Neuroepithelial trial results

Related conditions